Warfarin: no benefit over aspirin in ischaemic stroke prevention

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1315, 2001-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Assessment of the Secondary Prevention of Ischaemic Stroke with Dipyridamole plus Aspirin (Aggrenox ® /Asasantin ® ) in France

By Jean-Pierre Marissal Bernard Selke

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 661-670

Adis International

Access to resources Recommend Favorite

Aspirin and Heparin in Acute Ischaemic Stroke in Older Patients

By Gubitz G.J. Sandercock P.A.G.

Drugs & Aging, Vol. 15, Iss. 1, 1999-07 ,pp. : 29-36

Adis International

Access to resources Recommend Favorite

Aspirin cost effective for secondary prevention of ischaemic events

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 282, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Aspirin + dipyridamole preferable for stroke prevention

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Warfarin superior for stroke prevention in patients with AF

Inpharma, Vol. 1, Iss. 1601, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite